|
Day 1, Main Congress |
|||||||||||
|
Time/Room |
Grand Ballroom, Level 3 |
Time/Room |
Residence 5 & 6, Level 3 |
Time/Room |
Residence 2, Level 3 |
||||||
|
08:00 – 09:30 |
Lung Transplantation Workshop Directors: Shaf Keshavjee, Canada | Balasubramoniam K R, India | Chua Yang Chong, Singapore Chairpersons: Susan Hendriarini Mety, Indonesia | SV Srikishna, India |
08:00 – 09:30 |
Paediatric Thoracic Surgery Workshop: Innovation, Robotics and the Future Chairpersons: Esther Chan Ern Hwei, Singapore | Khader Hussain, India |
08:00 – 10:00 |
Certification Course: Robotic Bronchoscopy Workshop Directors: Kyle Hogarth, United States | Calvin Sze Hang Ng, Hong Kong SAR | Annez Admed, Singapore | Melvin Tay, Singapore |
||||||
|
08:00 – 08:15 |
Lung Transplantation in Asia: Current Status, Unmet Needs and Future Opportunities Kamran Ali, India |
08:00 – 08:15 |
Minimally Invasive Management of CCAM Hisashi Saji, Japan |
Coming Soon |
|||||||
|
08:15 – 08:30 |
Selecting the Right Recipient: Indications, Timing of Referral and Contraindications Balasubramoniam K R, India |
08:15 – 08:30 |
Robotic Paediatric Thoracic Surgery Chenghao Chen, China |
||||||||
|
08:30 – 08:45 |
Donor Lung Assessment, Retrieval and Optimisation Chua Yang Chong, Singapore |
08:30 – 08:45 |
Tracheal Diseases, Resections and Reconstruction Vu Huu Vinh, Vietnam |
||||||||
|
08:45 – 09:00 |
Expanding the Donor Pool: Extended-Criteria Donors, DCD and Novel Preservation Strategies |
08:45 – 09:00 |
Minimally Invasive Surgery for Paediatric Mediastinal and Esophageal Disorders Huang Jin Xi, China |
||||||||
|
09:00 – 09:15 |
Ex Vivo Lung Perfusion: Principles, Evidence and Practical Implementation Shaf Keshavjee, Canada |
09:00 – 09:15 |
Where Will Paediatric Thoracic Surgery Be in ASEAN 2035? Huang Jin Xi, China |
||||||||
|
09:15 – 09:30 |
[Panel Discussion] Bridging the Donor–Recipient Gap in Asia |
|
|||||||||
|
09:30 – 10:00 |
Coffee/Tea Break, Exhibition & E-Poster Viewing |
||||||||||
|
10:00 – 12:00 |
Lung Transplantation Workshop Chairpersons: Edmund Empaces Villaroman, Philippines | Nguyen Hoang Binh, Vietnam |
10:00 – 12:00 |
Symposium 1: Stage IV Lung Cancer – Time for Cure |
|
|||||||
|
10:00 – 10:15 |
Technical Masterclass: Bilateral Sequential Lung Transplantation Shaf Keshavjee, Canada |
10:00 – 10:15 |
Stage IV Lung Cancer: Who Can We Cure? Defining the Oligometastatic State Tim Benepal, United States |
||||||||
|
10:15 – 10:30 |
Anaesthesia, ECMO and Intraoperative Management During Lung Transplantation Lim Chong Hee, Singapore |
10:15 – 10:30 |
The Biology of Metastatic Lung Cancer: What Makes Stage IV Disease Curable? Sophia Wong, Singapore |
||||||||
|
10:30 – 10:45 |
The First 72 Hours: ICU Management and Primary Graft Dysfunction Kamen Valchanov, Singapore |
10:30 – 10:45 |
How to Select Patients for Local Consolidative Therapy in Stage IV Lung Cancer Voon Pei Jye, Malaysia |
||||||||
|
10:45 – 11:00 |
Immunosuppression, Infection Prevention and Management of Acute Rejection Balasubramoniam K R, India |
10:45 – 11:00 |
Radiotherapy in Oligometastatic Lung Cancer: When and How Much? Ivy Ng, Singapore |
||||||||
|
11:00 – 11:15 |
Long-Term Outcomes: CLAD, Surveillance, Rehabilitation and Quality of Life Irene Bello, Spain |
11:00 – 11:15 |
Lung Transplantation for Lung Cancer: A New Frontier for Curative Treatment? Ramaswamy Govindan, United States |
||||||||
|
11:15 – 11:30 |
[Case Discussion] Multidisciplinary Case Conference: A Complex Lung Transplant Journey |
11:15 – 11:30 |
[Panel Discussion] Stage IV Lung Cancer – Time for Cure |
||||||||
|
11:30 – 12:00 |
Key takeaways and Closing Remarks |
|
|||||||||
|
12:00 – 13:00 |
Lunch Break & Exhibition |
||||||||||
|
Room |
Grand Ballroom, Level 3 |
Room |
Residence 5 & 6, Level 3 |
Room |
Residence 2, Level 3 |
||||||
|
13:00 – 14:30 |
Symposium 2: SEATS x JACS Segmentectomy for Early Lung Cancer: Precision Surgery Comes of Age Chairpersons: Soon Sing Yang, Malaysia | Ong Boon Hean, Singapore |
13:30 – 15:00 |
Symposium 3: Next-Generation Targeted Therapies in Advanced Lung Cancer Chairperson: Tim Benepal, United States | Jens Samol, Singapore |
13:30 – 15:00 |
Symposium 4: Peripheral Pulmonary Nodules Chairperson: Brian Chua, Singapore | Phan Nguyen, Australia |
||||||
|
13:00 – 13:45 |
Has Segmentectomy Become the New Standard? Shinichi Toyooka, Japan |
13:00 – 13:45 |
EGFR: The Next Generation of EGFR-Targeted Therapy Pasi Janne, United States |
13:30 – 13:50 |
Evidence-based Lung Cancer Screening in Southeast Asia: Eligibility, Implementation and Equity Thitiwat Sriprasat, Thailand |
||||||
|
13:45 – 14:00 |
Planning the Perfect Segmentectomy Mariko Fukui, Japan |
13:45 – 14:00 |
ALK: Optimising Targeted Therapy in ALK-Positive Lung Cancer Jennifer Leong, Malaysia |
13:50 – 14:10 |
Bronchial Branch Tracing from CT Anatomy to Bronchoscopic Pathway Planning Clare Fong, Singapore |
||||||
|
14:00 – 14:15 |
Technical Masterclass Atsushi Kamigaichi, Japan |
14:00 – 14:15 |
HER2: The Expanding Therapeutic Landscape of HER2-Mutant Lung Cancer Ullas Batra, India |
14:10 – 14:30 |
Guided Bronchoscopy for Peripheral Nodules: Steering, Lesion Confirmation And Tissue Sampling Kho Sze Shyang, Malaysia |
||||||
|
14:15 – 14:30 |
Pathology and Oncology Considerations in Segmentectomy Calvin Ng, Hong Kong SAR |
14:15 – 14:30 |
Translational Research in Oncology & Opportunities: The ETOP Experience Rolf Stahel, Switzerland |
14:30 – 14:50 |
Robot-Assisted Bronchoscopy In 2026: Indications, Evidence, Workflow and Implementation Wang Hai, China |
||||||
|
14:30 – 14:45 |
The Future of Lung-Sparing Surgery Hisashi Saji, Japan |
14:30 – 15:00 |
[Panel Discussion] Next-Generation Targeted Therapies in Advanced Lung Cancer |
14:50 – 15:00 |
[Panel Discussion] Peripheral Pulmonary Nodules |
||||||
|
14:45 – 15:00 |
[Panel Discussion] Segmentectomy vs Lobectomy: Have We Reached the Tipping Point? |
||||||||||
|
15:00 – 15:30 |
Coffee/Tea Break, Exhibition & E-Poster Viewing |
||||||||||
|
15:30 – 17:00 |
Symposium 5: SEATS x KSTS The Future of Thoracic Surgery: AI, Robotics and Next-Generation Minimally Invasive Surgery Chairpersons: John Tam, Singapore | Boonlawat Homvises, Thailand |
15:30 – 17:00 |
Symposium 6: Management in Unresectable Stage III Disease Chairperson: Ramaswamy Govindan, United States | Jennifer Leong, Malaysia |
15:30 – 17:00 |
Symposium 7: Staging and Interventions in Thoracic Oncology Chairperson: Clare Fong, Singapore | Eugene Gan, Singapore |
||||||
|
15:30 – 15:45 |
Artificial Intelligence in Lung Cancer Screening: From Early Detection to Risk Prediction the Korean experience Kwon Joong Na, Republic of Korea |
15:30 – 15:45 |
Optimizing Radiotherapy Dosing, Fractionation, and Target Volume Delineation for Unresectable Stage III Disease Ivy Ng, Singapore |
15:30 – 15:50 |
Mediastinal Staging In 2026: Indications, Controversies and Guideline Updates Phan Nguyen, Australia |
||||||
|
15:45 – 16:00 |
Uniportal Robotic Surgery for Mediastinal Tumours: Is It the Next Frontier? Young Ho Yang, Republic of Korea |
15:45 – 16:00 |
Modern Thoracic Radiotherapy Techniques: Proton Therapy and Advanced Motion Management in Unresectable Stage III NSCLC Connie Yip, Singapore |
15:50 – 16:10 |
Systematic Mediastinal Staging: How I Do It – Nodal Mapping, Sampling Sequence and Specimen Adequacy Eric D. Tenda, Indonesia |
||||||
|
16:00 – 16:15 |
Single-Port Robotic Lobectomy and Segmentectomy: Current Evidence and Early Experience Hyun Koo Kim, Republic of Korea |
16:00 – 16:15 |
Evolving Systemic Paradigms: Consolidation Immunotherapy, Novel Combinations, and Targeted Approaches Post-Chemoradiation Jens Samol, Singapore |
16:10 – 16:30 |
EBUS after Neoadjuvant Therapy: Restaging, False-Negative Risk and the Need For Surgical Confirmation Carrie Leong, Singapore |
||||||
|
16:15 – 16:30 |
Single-Port Robotic Esophagectomy: Technical Evolution and Clinical Outcomes Seong Yong Park, Republic of Korea |
16:15 – 16:30 |
Navigating Radiation Pneumonitis, irAEs, and Response Monitoring in Locally Advanced Disease Rogelio Velasco Jr., Philippines |
16:30 – 16:50 |
Pleural Interventions in Lung Cancer: Diagnosis, Staging And Symptom Control Ronald Fajardo, Philippines |
||||||
|
16:30 – 16:45 |
What’s Next? Digital Thoracic Surgery, Augmented Reality, Digital Twins and Autonomous Robotics Christopher Cao, Australia |
16:30 – 17:00 |
[Panel Discussion] Management in Unresectable Stage III Disease |
16:50 – 17:00 |
[Panel Discussion] Staging and Interventions in Thoracic Oncology |
||||||
|
16:45 – 17:00 |
[Panel Discussion] The Next Decade of Thoracic Surgery: Which Technologies Will Change Our Practice? |
||||||||||
|
17:00 – 18:15 |
Symposium 8: Women in Thoracic Surgery Chairpersons: Cynthia Chia Ming Li, Singapore | Esther Chan Ern Hwei, Singapore | Franca Melfi, Italy |
17:00 – 18:15 |
Symposium 9: Next-Generation Thoracic Oncology Drug Development Chairperson: Rolf Stahel, Switzerland | Aaron Tan, Singapore |
17:00 – 18:15 |
Symposium 10: Central Airway Disorders Chairperson: Melvin Tay, Singapore | Kho Sze Shyang, Malaysia |
||||||
|
17:00 – 17:10 |
Women in Thoracic Surgery: Where Are We Today? Cynthia Chia Ming Li, Singapore |
17:00 – 17:15 |
The Future of Precision Drug Development in Thoracic Oncology: From Target Discovery to Transformative Therapies Pasi Janne, United States |
17:00 – 17:20 |
Malignant Central Airway Obstruction: Assessment, Stabilisation and Multimodality Treatment Khai Lip Ng, Malaysia |
||||||
|
17:10 – 17:20 |
Building a Successful Academic and Clinical Career in Thoracic Surgery Susan Hendriarini Mety, Indonesia |
17:15 – 17:30 |
The China Innovation Engine: Accelerated Drug Discovery, Next-Gen ADCs, and Global Partnerships in Thoracic Oncology Jiefei Han, China |
17:20 – 17:40 |
Para-Toluenesulfonamide For Malignant Central Airway Obstruction: Mechanism, Evidence and Practical Use Zhong Changhao, China |
||||||
|
17:20 – 17:30 |
Leadership Without Limits: Moving from Participation to Decision-Making Doreen Chew, Singapore |
17:30– 17:45 |
Executing First-in-Human and Phase I Oncology Trials in Asia Pei Jye Voon, Malaysia |
17:40 – 18:00 |
Airway Complications After Thoracic Surgery: Recognition, Prevention and Bronchoscopic Management Hari Kishan Gonuguntla, India |
||||||
|
17:30 – 17:40 |
Mastering Minimally Invasive and Robotic Thoracic Surgery Sabita Jiwnani, India |
17:45 – 18:00 |
Beyond Checkpoint Blockade: Next Generation Immunotherapies Sophia Wong, Singapore |
18:00 – 18:20 |
Benign Central Airway Obstruction: A Mechanistic and Morphologic Approach Brian Chua, Singapore |
||||||
|
17:40 – 17:50 |
Innovation and Entrepreneurship: Women Driving the Future of Thoracic Technology Rainbow Lau, Hong Kong SAR |
18:00 – 18:15 |
[Panel Discussion] Next-Generation Thoracic Oncology Drug Development |
18:20 – 18:30 |
[Panel Discussion] Central Airway Disorders |
||||||
|
17:50 – 18:00 |
Research, Publications and International Collaboration: Creating Global Influence Lara Lapeña-Kare, Phillippines |
|
|||||||||
|
18:00 – 18:10 |
Mentorship, Sponsorship and Building the Next Generation of Women Surgeons Franca Melfi, Italy |
||||||||||
|
18:10 – 18:20 |
Pregnancy, Parenthood and Surgical Training: Creating Supportive Career Pathways Esther Chan Ern Hwei, Singapore |
||||||||||
|
18:20 – 18:30 |
Resilience, Well-Being and Longevity in a Demanding Surgical Career Irene Bello, Spain |
||||||||||
|
19:00 – 21:00 |
SEATS 2026 Faculty Dinner (Offsite – By Invite Only) |
||||||||||
|
Day 2, Main Congress |
|||||||||||
|
Time/Room |
Grand Ballroom, Level 3 |
||||||||||
|
09:00 – 11:00 |
Symposium 11: Stage 3B Lung Cancer Discussion From Unresectable to Resectable – The Modern Multidisciplinary Journey Chairpersons: Bold Altangerel, Mongolia | Punnarerk Thongcharoen, Thailand | Luong Van Dinh, Vietnam |
||||||||||
|
09:00 – 09:12 |
Staging Stage IIIB NSCLC: EBUS, PET-CT, Molecular Testing and Determining Resectability Alan Sihoe, Hong Kong SAR |
||||||||||
|
09:12 – 09:24 |
Can Stage IIIB Be Operated On? Current Definitions of Resectability and Surgical Selection Agasthian Thirugnanam, Singapore |
||||||||||
|
09:24 – 09:36 |
Neoadjuvant Immunotherapy and Chemo-Immunotherapy: Changing the Treatment Paradigm Surein Arulananda, Australia |
||||||||||
|
09:36 – 09:48 |
Technical Challenges of Surgery After Induction Therapy: Tips, Pitfalls and Outcomes Gavin Wright, Australia |
||||||||||
|
09:48 – 10:00 |
Definitive Chemoradiation or Trimodality Therapy? Where Does Radiation Fit? Connie Yip, Singapore |
||||||||||
|
10:00 – 10:12 |
Biomarkers, ctDNA and Response Assessment: Selecting Patients for Conversion Surgery David Lee, Malaysia |
||||||||||
|
10:12 – 10:24 |
Conversion Surgery for Initially Unresectable Stage IIIB Disease: Evidence, Outcomes and Future Directions Abbas E Abbas, United States |
||||||||||
|
10:24 – 10:36 |
Adjuvant Therapy After Surgery: Immunotherapy, Targeted Therapy and Long-Term Surveillance Molly Li, Hong Kong SAR |
||||||||||
|
10:36 – 11:00 |
Case Presentation 3B by Oncologist |
||||||||||
|
11:00 – 11:30 |
Opening Ceremony |
||||||||||
|
11:30 – 12:30 |
Contemporary Management of Resectable NSCLC: Surgical Strategies and Perioperative Therapy to Optimise Curative Intent
|
||||||||||
|
11:45 – 11:48 |
Welcome and Faculty Introduction Harish Mithiran, Singapore |
||||||||||
|
11:48– 12:08 |
Surgical Success in Resectable NSCLC: Streamlining Perioperative IO Incorporation Rainbow Lau, Hong Kong SAR |
||||||||||
|
12:08– 12:28 |
Maximising Outcomes in Resectable NSCLC: Real-world Insights from KEYNOTE-671 Derek De-Rui Huang, Taiwan |
||||||||||
|
12:28– 12:30 |
Closing Remarks Harish Mithiran, Singapore |
||||||||||
|
12:30 – 14:00 |
Symposium 12: Rare/Uncommon Cancers in the Thoracic Malignancies: A Multidisciplinary Approach to Challenging Tumours Chairpersons: Nelson Bambalan, Philippines | Saladdin Tjokronegoro, Indonesia | Somcharoen Saetang, Thailand |
||||||||||
|
12:30 – 12:42 |
Thymic Epithelial Tumours: Contemporary Management from Early to Advanced Disease Ong Boon Hean, Singapore |
||||||||||
|
12:42 – 12:54 |
Malignant Pleural Mesothelioma: Surgery, Systemic Therapy and the Future of Multimodality Care Tim Benepal, United Kingdom |
||||||||||
|
12:54 – 13:06 |
Harnessing Artificial Intelligence Across the Spectrum of Lung Cancer Surein Arulananda, Australia |
||||||||||
|
13:06 – 13:18 |
Pulmonary Neuroendocrine Tumours: Diagnosis, Classification and Treatment Strategies Akif Turna, Türkiye |
||||||||||
|
13:18 – 13:30 |
SMARCA4-Deficient and Other Molecularly Defined Rare Thoracic Tumours: New Biology, New Therapeutic Opportunities David Lee, Malaysia |
||||||||||
|
13:30 – 13:42 |
Chest Wall Sarcomas and Rare Pleural Tumours: Surgical Principles and Reconstruction Strategies Narasimman Sathiamurthy, Malaysia |
||||||||||
|
13:42 – 14:00 |
Case Presentation by Singapore Junior |
||||||||||
|
14:00 – 14:30 |
Coffee/Tea Break, Exhibition & E-Poster Viewing |
||||||||||
|
Room |
Grand Ballroom, Level 3 |
||||||||||
|
14:30 – 15:30 |
Symposium 13: Recap by Pulmonologist, Surgeon & Oncologist (Top 10 papers of the Year) Surgery: Alan Sihoe, Hong Kong SAR Pulmonology: Kyle Hogarth, United States Onocology: Ramaswamy Govindan, United States |
||||||||||
|
Room |
Residence 5 & 6, Level 3 |
Room |
Residence 2, Level 3 |
||||||||
|
15:30 – 17:00 |
Symposium 14: SEATS x TSTS x HKTS Chairpersons: Tuo Sothunea, Cambodia | Adli Azam B in Mohammad Razi, Malaysia | Fernando Melendres, Philippines |
15:30 – 17:00 |
Symposium 15: Young Investigation Award Presentations |
||||||||
|
15:30 – 15:35 |
Opening Remarks: The Emerging Precision Pathway for Early Lung Cancer |
15:30 – 15:35 |
Coming Soon |
||||||||
|
15:35 – 15:45 |
Constructing a Hybrid Operating Room Edmund Villaroman, Philppines |
15:35 – 15:45 |
|||||||||
|
15:45 – 15:55 |
Improving Diagnostic Yield in Robotic Bronchoscopy: Cone-Beam CT, Mobile 3D Imaging and Advanced Confirmation Tools Kyle Hogarth, United States |
15:45 – 15:55 |
|||||||||
|
15:55 – 16:05 |
Bronchoscopic Tumour Ablation: Microwave, Radiofrequency, Cryoablation and Emerging Energy Technologies Calvin Sze Hang Ng, Hong Kong SAR |
15:55 – 16:05 |
|||||||||
|
16:05 – 16:15 |
The Latest Advances in Uniportal Robotic Segmentectomy: Port Strategy, Instrumentation and Complex Segmental Resections Po-Kuei Hsu, Taiwan |
16:05 – 16:15 |
|||||||||
|
16:15 – 16:25 |
Precision Segmentectomy: 3D Reconstruction, AI-Assisted Planning, Fluorescence and Intraoperative Navigation Kuan-Hsun Lin, Taiwan |
16:15 – 16:25 |
|||||||||
|
16:25 – 16:35 |
The One-Stop Lung Cancer Pathway: From Robotic Biopsy and Localisation to Same-Session Surgical Resection Rainbow Lau, Hong Kong SAR |
16:25 – 16:35 |
|||||||||
|
16:35 – 17:00 |
[Panel Discussion] Will Technology Redefine the Management of Early Lung Cancer? |
16:35 – 17:00 |
|||||||||
|
19:00 – 21:30 |
SEATS 2026 Gala Dinner (Ticketed) |
||||||||||
|
Day 3, Main Congress |
||||||||||||||
|
Time/Room |
Grand Ballroom, Level 3 |
|||||||||||||
|
09:00 – 10:30 |
Symposium 16: The Trachea as a Multidisciplinary Frontier Chairpersons: Abbas E Abbas, United States | M. Odbaatar, Mongolia | Franca Melfi, Italy |
|||||||||||||
|
09:03 – 09:15 |
Managing the Compromised Central Airway: Diagnosis, Bronchoscopic Intervention and Bridging to Definitive Treatment Hari Kishan Gonuguntla, India |
|||||||||||||
|
09:15 – 09:27 |
Primary Tracheal Malignancies: Histology-Directed Systemic Therapy, Radiotherapy and Multimodality Decision-Making Ivy Ng, Singapore |
|||||||||||||
|
09:27 – 09:39 |
Benign Tracheal Stenosis: When to Dilate, When to Stent and When to Resect Ramkaran Chaudhary, India |
|||||||||||||
|
09:39 – 09:51 |
Choice of Graft for Trachea Replacement: Homograft/Synthetic/3D Reconstructed Hasan Batırel, Türkiye |
|||||||||||||
|
09:51 – 10:03 |
Tracheal Tumours: Principles of Resection, Margin Assessment and Reconstruction Yang Hao Xian, China |
|||||||||||||
|
10:03 – 10:03 |
Carinal and Extended Tracheal Resections: Technical Strategies, Anastomotic Protection and Rescue Shaf Keshavjee, Canada |
|||||||||||||
|
10:03 – 10:15 |
Tracheobronchoplasty and Robotic Tracheal Reconstruction Wenjie Jiao, China |
|||||||||||||
|
10:15 – 10:27 |
Paedetric Trachea Resection & Reconstruction Jin Xi Huang, China |
|||||||||||||
|
10:30 – 11:00 |
Coffee/Tea Break, Exhibition & E-Poster Viewing |
|||||||||||||
|
11:00 – 12:30 |
Symposium 17: Hot Topics Chairpersons: Kyle Hogarth | Punnarerk Thongcharoen, Thailand | Htek Myek, Myanmar | Le Tien Dung, Vietnam |
|||||||||||||
|
11:00 – 11:12 |
Anaesthesia for Non-Intubated Thoracic Surgery: Regional Techniques, Sedation and Maintaining Spontaneous Ventilation Chompunoot Pathonsamit, Thailand |
|||||||||||||
|
11:12 – 11:24 |
NIVATS in Practice: Patient Selection, Surgical Technique and Conversion Protocols Sira Laothai, Thailand |
|||||||||||||
|
11:24 – 11:36 |
Minimally invasive surgery for infective and infalammatory diseases in south asia Ramkaran Chaudhary, India |
|||||||||||||
|
11:36 – 11:48 |
Thoracic Surgery in Mongolia: Current Practice, Challenges and Opportunities for Regional Collaboration Bold Altangerel, Mongolia |
|||||||||||||
|
11:48 – 12:00 |
Artificial Intelligence in Thoracic Surgery: From Preoperative Planning to Intraoperative Decision Support Gavin Wright, Australia |
|||||||||||||
|
12:00 – 12:12 |
Diaphragm Surgery: Minimally Invasive Repair, Reconstruction and Management of Paralysis Yin Kai Chao, Taiwan |
|||||||||||||
|
12:12 – 12:24 |
Augmented Reality, Navigation and 3D Technologies: The Next Operating-Room Interface Christopher Cao, Australia |
|||||||||||||
|
12:24 – 12:30 |
[Panel Discussion] Expert panel discussion and audience questions |
|||||||||||||
|
12:30 – 13:30 |
Lunch Break & Exhibition |
|||||||||||||
|
13:30 – 14:30 |
Symposium 18: Healthcare Sustainability by SEATS Sustainability Initiative Chairperson: Aneez Ahmed, Singapore |
|||||||||||||
|
13:30 – 13:37 |
What is Healthcare Sustainability? Amanda Zain, Singapore |
|||||||||||||
|
13:37 – 13:44 |
Sustainability in Thoracic Surgery |
|||||||||||||
|
13:44 – 13:51 |
Sustainability in Oncology Roselle de Guzman, Philippines |
|||||||||||||
|
13:51 – 13:58 |
Sustainability in Respiratory Medicine See Kay Choong, Singapore |
|||||||||||||
|
13:58 – 14:05 |
Sustainability in Anaesthesia Poh Pei Kee, Singapore |
|||||||||||||
|
14:05 – 14:12 |
Sustainability in Industry Benish Aslam, Singapore |
|||||||||||||
|
14:12 – 14:19 |
SEATS Sustainability Initiative Lowell Leow, Singapore |
|||||||||||||
|
14:19– 14:30 |
Q&A |
|||||||||||||
|
14:30 – 15:00 |
Coffee/Tea Break, Exhibition & E-Poster Viewing |
|||||||||||||
|
15:00 – 16:00 |
Symposium 19: Quiz Cup |
|||||||||||||
|
16:00 – 16:30 |
Closing & Award Ceremony |
|||||||||||||
|
15 November 2026, Sunday | Multi-Disciplinary Lung Cancer Conference (MLCC) |
|
|
Time/Room |
Grand Ballroom, Level 3 |
|
08:00 – 08:30 |
Morning Registration & Exhibition Viewing |
|
08:30 – 09:00 |
Networking |
|
09:00 – 09:05 |
Welcome Address Amit Jain, Singapore |
|
09:05 – 09:50 |
Plenary Discussion | Making Incurable Lung Cancers a Chronic Disease – Are We There Yet? |
|
09:50 – 10:05 |
Networking Coffee Break & Exhibition Viewing |
|
10:05 – 10:50 |
Session 1 | Beyond Small Molecule Inhibitors in Oncogene Driven Cancers Part 1 – EGFR |
|
Upfront treatments and sequencing for lifetime mutant care |
|
|
Tackling rare mutations and horizon treatments |
|
|
Rational cost-effective care for EGFR mutant lung cancer |
|
|
10:50 – 11:05 |
Networking Coffee Break & Exhibition Viewing |
|
11:05 – 12:05 |
Session 2 | Beyond Small Molecule Inhibitors Part 2 – Other Oncogene Driven Lung Cancers |
|
Improving OS in ALK+ lung cancers & early-stage cure rates |
|
|
MET & BRAF: Upfront vs. delayed TKI, ICI, sequencing, and chemo |
|
|
KRAS insights: Timing, pairing, and sequencing for ideal outcomes |
|
|
HER2 driven lung cancers: Current and emerging modalities |
|
|
12:05 – 13:30 |
Grand Networking Luncheon |
|
13:30 – 14:15 |
Session 3 | Functionalising Multi-Omic Interrogation to Guide Rational Individualized Treatments |
|
Next-generation multiplexed AI-powered pathology: Research to translation |
|
|
Multi-disciplinary molecular tumor boards for n=1 treatments |
|
|
Practical Case Studies |
|
|
14:15 – 14:30 |
Networking Coffee Break & Exhibition Viewing |
|
14:30 – 15:15 |
Session 4 | Small Cell Lung Cancer – At the Horizon and Beyond |
|
Targeting DLL3 with T cells: How Tarlatamab changed the equation |
|
|
Beyond DLL3: Novel targets and drug development strategies for SCLC |
|
|
Combination and sequencing in SCLC: What is on the horizon |
|
|
15:15 – 15:30 |
Networking Coffee Break & Exhibition Viewing |
|
15:30 – 16:15 |
Session 5 | Identifying Immunogenic Lung Cancers and Sustaining Anti-Cancer Immunity |
|
Beyond the singularity of ICIs: Predicting and sustaining responses |
|
|
Poly-epitope and poly-targeting cancer therapies (TILs, etc.) |
|
|
B7H3 as a novel target: Pushing boundaries with ADCs, BiTEs, CAR-T, and TILs |
|
|
16:15 – 16:30 |
Poster Prize Giving and Closing Remarks |
Disclaimer:
The programme is accurate as of the time of publication. The organisers reserve the right to amend, vary, or withdraw any part of the Event programme, including but not limited to activities, session topics, speakers, or schedules, where circumstances so require. Such amendments shall not constitute grounds for refund or compensation
